Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Radio

Top Emerging Market Currency Picks: Indian Rupee, Turkish Lira, Mexican Peso
Radio Feature 38: Bart Turtelboom in conversation with Sona Blessing
 
Thursday, February 02, 2012 - Fonds’12, Zurich
radio Bart Turtelboom is managing director and co-head of global emerging markets at GLG Partners.
Amongst others, he has been an economist at the International Monetary Fund in Washington, and as a director at Deutsche Bank, he was responsible for covering its large clients in emerging markets.
In a “live” interview he shares why be believes emerging market currencies amongst all the risky assets in the world are "if not the most compelling", certainly one of the most compelling investment opportunities in 2012. Why his top picks are the Indian Rupee, Turkish Lira and Mexican Peso. He elaborates on whether inflation poses a threat, and shares his take on the likely timeframe and process to be followed in the internationalisation of the Chinese Yuan.

 Download this feature as MP3 (5.46 MB)

 
Listen to the complete feature
Top Emerging Market Currency Picks: Indian Rupee, Turkish Lira, Mexican Peso

Duration: 05:57 

 

Or listen to selected sub-features
  • Q1 - Why invest in global emerging market currencies?

    Duration: 01:59 


  • Q2 - How should investors go about investing in global emerging market currencies?

    Duration: 00:36 


  • Q3 - Is this “the right time” to invest in emerging market currencies?

    Duration: 01:01 


  • Q4 - Favourite currency pairs?

    Duration: 01:14 


  • Q5 - Doesn't inflation pose a threat?

    Duration: 00:33 


  • Q6 - The internationalisation of the Chinese Yuan?

    Duration: 00:31 



Radio Link
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its